A randomized, double-blind, placebo-controlled, parallel-design, multiple-site clinical study
to evaluate the therapeutic equivalence and safety of ivermectin cream 1% (Actavis
Laboratories UT, Inc.) to SoolantraTM (ivermectin) cream 1% (Galderma) in the treatment of
moderate to severe papulopustular rosacea.